Scholarly Index
Simon M. Collin
AstraZeneca (United Kingdom); 5,092 total citations; 204 total publications; best world rank #48
AstraZeneca (United Kingdom)
5,092Total citations
204Total publications
39H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Fibromyalgia and Chronic Fatigue Syndrome Research | Lifetime | 547 | GB 67 | 95.70 |
| Health, psychology, and well-being | Lifetime | 619 | GB 109 | 93.37 |
| Leprosy Research and Treatment | Lifetime | 397 | GB 43 | 90.83 |
| Leprosy Research and Treatment | 2021-2025 | 48 | GB 4 | 91.59 |
| Mycobacterium research and diagnosis | 2021-2025 | 992 | GB 60 | 81.81 |
| Streptococcal Infections and Treatments | 2021-2025 | 705 | GB 28 | 78.50 |
| Infectious Diseases and Tuberculosis | 2021-2025 | 542 | GB 39 | 78.26 |
| Neonatal and Maternal Infections | 2021-2025 | 474 | GB 43 | 70.93 |